Paper37170010
Oncogenic metabolic reprogramming in breast cancer: focus on signaling pathways and mitochondrial genes.
Malayil R and 6 others. Med Oncol, 2023. Cited by 18 papers, by iCite.
Cite this record
ConductScience Library. Oncogenic metabolic reprogramming in breast cancer: focus on signaling pathways and mitochondrial genes. Papers, record 37170010. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37170010
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Oncogenic metabolic reprogramming in breast cancer: focus on signaling pathways and mitochondrial genes.
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Phosphatidylinositol 3-Kinases | Major topic |
| Neoplasms | Major topic |
| Humans | |
| Genes, Mitochondrial | |
| Signal Transduction | |
| Glycolysis |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| KL1216200313 | University Grants Commission, India | PubMed | ||
| 09/1051(0038)/2019-EMR-1 | Council for Scientific and Industrial Research India | PubMed | ||
| 09/1051(0042)/2019-EMR-1 | Council for Scientific and Industrial Research, India | PubMed | ||
| SRG/2021/001806 | Science and Engineering Research Board | PubMed |
Source PubMed
References131
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30978340 | KDM5B promotes breast cancer cell proliferation and migration via AMPK-mediated lipid metabolism reprogramming. | Exp Cell Res | 2019 | https://conductscience.org/library/papers/30978340 | PubMed |
| 2 | 19629070 | Targeting PI3K signalling in cancer: opportunities, challenges and limitations. | Nat Rev Cancer | 2009 | https://conductscience.org/library/papers/19629070 | PubMed |
| 3 | 30471920 | Crosstalk between Estrogen Signaling and Breast Cancer Metabolism. | Trends Endocrinol Metab | 2019 | https://conductscience.org/library/papers/30471920 | PubMed |
| 4 | 27872091 | Macrophage-Secreted TNFα and TGFβ1 Influence Migration Speed and Persistence of Cancer Cells in 3D Tissue Culture via Independent Pathways. | Cancer Res | 2017 | https://conductscience.org/library/papers/27872091 | PubMed |
| 5 | 31548545 | Breast cancer. | Nat Rev Dis Primers | 2019 | https://conductscience.org/library/papers/31548545 | PubMed |
| 6 | 8221565 | Overexpression of Glut-1 glucose transporter in human breast cancer. An immunohistochemical study. | Cancer | 1993 | https://conductscience.org/library/papers/8221565 | PubMed |
| 7 | 25730670 | Mitochondrial control by DRP1 in brain tumor initiating cells. | Nat Neurosci | 2015 | https://conductscience.org/library/papers/25730670 | PubMed |
| 8 | 33489906 | The Metabolic Mechanisms of Breast Cancer Metastasis. | Front Oncol | 2020 | https://conductscience.org/library/papers/33489906 | PubMed |
| 9 | 32872164 | Fatty Acid Synthase: An Emerging Target in Cancer. | Molecules | 2020 | https://conductscience.org/library/papers/32872164 | PubMed |
| 10 | 25093804 | Signaling pathways in breast cancer: therapeutic targeting of the microenvironment. | Cell Signal | 2014 | https://conductscience.org/library/papers/25093804 | PubMed |
| 11 | 26199863 | Small molecules inhibiting the nuclear localization of YAP/TAZ for chemotherapeutics and chemosensitizers against breast cancers. | FEBS Open Bio | 2015 | https://conductscience.org/library/papers/26199863 | PubMed |
| 12 | 26862496 | Targeting metabolism in breast cancer: How far we can go? | World J Clin Oncol | 2016 | https://conductscience.org/library/papers/26862496 | PubMed |
| 13 | 32509379 | The role of mitochondrial dynamics in human cancers. | Am J Cancer Res | 2020 | https://conductscience.org/library/papers/32509379 | PubMed |
| 14 | 29459886 | DNA Damage, Repair, and Cancer Metabolism. | Front Oncol | 2018 | https://conductscience.org/library/papers/29459886 | PubMed |
| 15 | 31160567 | Activation of Aurora A kinase increases YAP stability via blockage of autophagy. | Cell Death Dis | 2019 | https://conductscience.org/library/papers/31160567 | PubMed |
| 16 | 28624623 | Mitochondrial fission forms a positive feedback loop with cytosolic calcium signaling pathway to promote autophagy in hepatocellular carcinoma cells. | Cancer Lett | 2017 | https://conductscience.org/library/papers/28624623 | PubMed |
| 17 | 30368881 | PKM2 promotes glucose metabolism through a let-7a-5p/Stat3/hnRNP-A1 regulatory feedback loop in breast cancer cells. | J Cell Biochem | 2019 | https://conductscience.org/library/papers/30368881 | PubMed |
| 18 | 21042748 | Mitochondrial genotype and breast cancer predisposition. | Oncol Rep | 2010 | https://conductscience.org/library/papers/21042748 | PubMed |
| 19 | 36059687 | IL-8 and its role as a potential biomarker of resistance to anti-angiogenic agents and immune checkpoint inhibitors in metastatic renal cell carcinoma. | Front Oncol | 2022 | https://conductscience.org/library/papers/36059687 | PubMed |
| 20 | 12496258 | Angiogenic effects of interleukin 8 (CXCL8) in human intestinal microvascular endothelial cells are mediated by CXCR2. | J Biol Chem | 2003 | https://conductscience.org/library/papers/12496258 | PubMed |
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 18 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41595746 | Recent Update Targeting Autophagy-Apoptosis Crosstalk Using Bioactive Natural Products for Ovarian Cancer Treatment. | Biomedicines | 2026 | https://conductscience.org/library/papers/41595746 | PubMed |
| 41234832 | TOP2A promotes non-small cell lung cancer progression via LDHA-mediated glycolysis and histone lactylation. | Transl Cancer Res | 2025 | https://conductscience.org/library/papers/41234832 | PubMed |
| 40806360 | Dark Sweet Cherry Anthocyanins Suppressed Triple-Negative Breast Cancer Pulmonary Metastasis and Downregulated Genes Associated with Metastasis and Therapy Resistance In Vivo. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40806360 | PubMed |
| 40259163 | Molecular mechanisms and clinical significance of perineural invasion in malignancies: the pivotal role of tumor-associated Schwann cells in cancer progression and metastasis. | Med Oncol | 2025 | https://conductscience.org/library/papers/40259163 | PubMed |
| 39483548 | Harnessing Epigenetic Mechanisms to Overcome Immune Evasion in Cancer: The Current Strategies and Future Directions. | Cureus | 2024 | https://conductscience.org/library/papers/39483548 | PubMed |
| 39473208 | Investigation of Apoptotic and Anticancer Effects of 2-substituted Benzothiazoles in Breast Cancer Cell Lines: EGFR Modulation and Mechanistic Insights. | Anticancer Agents Med Chem | 2025 | https://conductscience.org/library/papers/39473208 | PubMed |
| 38946222 | Metabolomics analyses reveal the crucial role of ERK in regulating metabolic pathways associated with the proliferation of human cutaneous T-cell lymphoma cells treated with Glabridin. | Cell Prolif | 2024 | https://conductscience.org/library/papers/38946222 | PubMed |
| 38645412 | LINK-A: unveiling its functional role and clinical significance in human tumors. | Front Cell Dev Biol | 2024 | https://conductscience.org/library/papers/38645412 | PubMed |
| 38289431 | An overview of recent advancements in small molecules suppression of oncogenic signaling of K-RAS: an updated review. | Mol Divers | 2024 | https://conductscience.org/library/papers/38289431 | PubMed |
| 38058537 | Epigenome-Driven Strategies for Personalized Cancer Immunotherapy. | Cancer Manag Res | 2023 | https://conductscience.org/library/papers/38058537 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AKT1 | 207 | PubTator's text mining | https://conductscience.org/library/genes/207 | NCBI Gene |
| MAPK1 | 5594 | PubTator's text mining | https://conductscience.org/library/genes/5594 | NCBI Gene |
| MTOR | 2475 | PubTator's text mining | https://conductscience.org/library/genes/2475 | NCBI Gene |
| MYC | 4609 | PubTator's text mining | https://conductscience.org/library/genes/4609 | NCBI Gene |
| STAT3 | 6774 | PubTator's text mining | https://conductscience.org/library/genes/6774 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37170010
GET https://conductscience.org/api/papers/v1/37170010/references?page=2